9258 Wealth Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$211K Sell
3,142
-1,395
-31% -$115K 0.03% 337
2024
Q2
$514K Buy
4,537
+404
+10% +$51.1K 0.08% 183
2024
Q1
$573K Buy
4,133
+1,831
+80% +$230K 0.09% 179
2023
Q4
$286K Buy
+2,302
New +$235K 0.05% 261
2021
Q4
Sell
-1,616
Closed -$221K 372
2021
Q3
$221K Buy
+1,616
New +$204K 0.06% 317

Other funds holding DXCM

9258 Wealth Management's DXCM Position: Q3 2024 in Review

9258 Wealth Management reduced its DexCom (DXCM) stake by 31% in Q3 2024, selling an estimated $115K and leaving 3,142 shares worth $211K. The position accounts for 0.03% of the portfolio, ranked #337.

9258 Wealth Management first reported a position in DXCM in Q3 2021 and has held it in 5 quarters since. The position peaked at $573K in Q1 2024. 889 funds tracked by Wall St. Rank hold DXCM as of Q3 2024.

  • 9258 Wealth Management held 3,142 shares of DexCom worth $211K as of Q3 2024.
  • 9258 Wealth Management sold 1,395 DexCom shares in Q3 2024, an estimated $115K.
  • DexCom made up 0.03% of 9258 Wealth Management's portfolio in Q3 2024, its #337 holding.
  • 9258 Wealth Management first reported a position in DexCom in Q3 2021 and has held it in 5 quarters since.
  • 9258 Wealth Management's DexCom position peaked at $573K in Q1 2024.
  • 889 funds tracked by Wall St. Rank held DexCom as of Q3 2024.

Based on 9258 Wealth Management's 13F filing for Q3 2024, filed 12 Nov 2024.